ReviewDiscover oncology2026

Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy.

Emadeldin M Kamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.